Atrial Tachyarrhythmia Recurrence Temporal Patterns in Bradycardia Patients Implanted with Antitachycardia Pacemakers

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 1, 2004, Pages 44-51

  Ricci, Renato ^a,k   Santini, Massimo ^a   Padeletti, Luigi ^b   Boriani, Giuseppe ^c   Capucci, Alessandro ^d   Botto, Gianluca ^e   Gulizia, Michele ^f   Inama, Giuseppe ^g   Galati, Antonio ^h   Solimene, Francesco ⁱ   Pepe, Massimilano ^j   Grammatico, Andrea ^j  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Civile Hospital   (Italy)

^e SANT ANNA HOSPITAL   (Italy)

^f San Luigi S Currò Hospital   (Italy)

^g OSPEDALE MAGGIORE   (Italy)

^h Panico Hospital   (Italy)

ⁱ Institute of Cardiology   (Italy)

^j Medtronic Italia   (Italy)

^k NONE   (Italy)

more..

Author keywords

Atrial fibrillation; Atrial tachyarrhythmia recurrences; Clinical trial design; Exponential function; Pacemaker; Pacing; Power law function; Statistical modeling

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; SINUS BRADYCARDIA; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRADYCARDIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RECURRENCE; TACHYCARDIA, ECTOPIC ATRIAL; UNITED STATES;

EID: 9144273733     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03317.x     Document Type: Article

References (28)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG: Prevalence, age distribution and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995;155:469-473.
2. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991;22:983-988.
3. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB: Secular trends in the prevalence of atrial fibrillation, The Framingham study. Am Heart J 1996;131:790-795.
4. American Heart Association, 1998. Heart and Stroke Statistical Update 1997. Dallas, TX: American Heart Association, 1999;11:891-894.
5. Gajewski J, Singer RB: Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-1544.
6. Greer GS, Wilkinson WE, McCarthy EA, Pritchett EL: Random and nonrandom behaviour of symptomatic paroxysmal atrial fibrillation. Am J Cardiol 1989;64:339-342.
7. Pritchett EL, Hammill SC, Reiter MJ, Lee KL, McCarthy MA, Zimmerman JM, Shand DG: Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia. Am J Cardiol 1983;52:1007-1012.
8. Rose MS, Gillis AM, Sheldon RS: Evaluation of the bias in using the time to first event when the inter-event intervals have a Weibull distribution. Stat Med 1999;18:139-154.
9. Gillis AM, Rose MS: Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. Am J Cardiol 2000;85:1445-1450.
10. Kaemmerer WF, Rose S, Mehra R: Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: Implications for detection of treatment efficacy. J Cardiovasc Electrophysiol 2001;12:121-130.
11. Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani MC, Ricci R, Pignalberi C, Santini M, Puglisi A, Azzolini P, Spampinato A, Martelli M, Capucci A, Boriani G, Botto G, Proclemer A: Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142:1047-1055.
12. Kale M, Bennett DH: Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation. Europace 2003;5:123-131.
13. Funck RC, Adamec R, Lurje L, Capucci A, Ritter P, Shekan D, Slegers LC, Tavernier R, Ishikawa T: Atrial overdriving is beneficial in patients with atrial arrhythmias: First results of the PROVE Study. Pacing Clin Electrophysiol 2000;23(11 Pt II):1891-1893.
14. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hammill SC: Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001;104:1023-1028.
15. Gregoratos G, Cheitlin MD, Conill A, et al: ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998;97:1325-1335.
16. Israel CW, Hugl B, Unterberg C, Lawo T, Kennis I, Hettrick D, Hohnloser SH: Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128.
17. Swerdlow CD, Schöls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD: Detection of atrial fibrillation and flutter by a dual chamber implantable cardioverter-defibrillator. Circulation 2000;101:878-885.
18. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg J, DeSouza C: Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001;103:381-386.
19. Nelson W: Applied Life Data Analysis. New York: John Wiley & Sons, 1992:37-55.
20. Lee ET: Statistical Methods for Survival Data Analysis. New York: John Wiley & Sons, 1992:131-156.
21. Lindsey JK: Counts and time to events. Stat Med 1998;17:1745-1751.
22. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC: Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-227.
23. Gillis AM, Wyse DG, Connolly SJ, Dubuc M, Philippon F, Yee R, Lacombe P, Rose MS, Kerr CD: Atrial pacing peri-ablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553-2558.
24. Wijffels MCEF, Kirchhof EJHJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
25. Savelieva I, Camm AJ: Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4:369-382.
26. Pocock SJ: Clinical Trials: A Practical Approach. New York: John Wiley & Sons, 1983:110.
27. Shehadeh LA, Liebovitch LS, Wood MA: Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: Implications for assessing antiarrhythmic therapies. J Cardiovasc Electrophysiol 2002;13:303-309.
28. Coumel P: The various forms of clinical research concerning paroxysmal atrial fibrillation. Eur Heart J 1999;20:1369-1370.